The rise of Parkinson's disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and "eat, move, sleep" lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand
- PMID: 38803644
- PMCID: PMC11129688
- DOI: 10.3389/fneur.2024.1386608
The rise of Parkinson's disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and "eat, move, sleep" lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand
Abstract
The rising prevalence of Parkinson's disease (PD) globally presents a significant public health challenge for national healthcare systems, particularly in low-to-middle income countries, such as Thailand, which may have insufficient resources to meet these escalating healthcare needs. There are also many undiagnosed cases of early-stage PD, a period when therapeutic interventions would have the most value and least cost. The traditional "passive" approach, whereby clinicians wait for patients with symptomatic PD to seek treatment, is inadequate. Proactive, early identification of PD will allow timely therapeutic interventions, and digital health technologies can be scaled up in the identification and early diagnosis of cases. The Parkinson's disease risk survey (TCTR20231025005) aims to evaluate a digital population screening platform to identify undiagnosed PD cases in the Thai population. Recognizing the long prodromal phase of PD, the target demographic for screening is people aged ≥ 40 years, approximately 20 years before the usual emergence of motor symptoms. Thailand has a highly rated healthcare system with an established universal healthcare program for citizens, making it ideal for deploying a national screening program using digital technology. Designed by a multidisciplinary group of PD experts, the digital platform comprises a 20-item questionnaire about PD symptoms along with objective tests of eight digital markers: voice vowel, voice sentences, resting and postural tremor, alternate finger tapping, a "pinch-to-size" test, gait and balance, with performance recorded using a mobile application and smartphone's sensors. Machine learning tools use the collected data to identify subjects at risk of developing, or with early signs of, PD. This article describes the selection and validation of questionnaire items and digital markers, with results showing the chosen parameters and data analysis methods to be robust, reliable, and reproducible. This digital platform could serve as a model for similar screening strategies for other non-communicable diseases in Thailand.
Keywords: Parkinson’s disease; Thailand; digital interventions; lifestyle interventions; non-communicable diseases; prevention.
Copyright © 2024 Bhidayasiri, Sringean, Phumphid, Anan, Thanawattano, Deoisres, Panyakaew, Phokaewvarangkul, Maytharakcheep, Buranasrikul, Prasertpan, Khontong, Jagota, Chaisongkram, Jankate, Meesri, Chantadunga, Rattanajun, Sutaphan, Jitpugdee, Chokpatcharavate, Avihingsanon, Sittipunt, Sittitrai, Boonrach, Phonsrithong, Suvanprakorn, Vichitcholchai and Bunnag.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures









Similar articles
-
A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease.Neuroepidemiology. 2011;37(3-4):222-30. doi: 10.1159/000334440. Epub 2011 Dec 1. Neuroepidemiology. 2011. PMID: 22133707
-
Telemonitoring Parkinson's disease using machine learning by combining tremor and voice analysis.Brain Inform. 2020 Oct 22;7(1):12. doi: 10.1186/s40708-020-00113-1. Brain Inform. 2020. PMID: 33090328 Free PMC article.
-
Old problems, new solutions: harnessing technology and innovation in Parkinson's disease-evidence and experiences from Thailand.J Neural Transm (Vienna). 2024 Jun;131(6):721-738. doi: 10.1007/s00702-023-02727-1. Epub 2024 Jan 8. J Neural Transm (Vienna). 2024. PMID: 38189972 Review.
-
Parkinson's and Alzheimer's diseases in Costa Rica: a feasibility study toward a national screening program.Glob Health Action. 2013 Dec 27;6:23061. doi: 10.3402/gha.v6i0.23061. Glob Health Action. 2013. PMID: 24378195 Free PMC article.
-
Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective.J Parkinsons Dis. 2021;11(s1):S103-S109. doi: 10.3233/JPD-202428. J Parkinsons Dis. 2021. PMID: 33579873 Free PMC article. Review.
Cited by
-
A quantum inspired machine learning approach for multimodal Parkinson's disease screening.Sci Rep. 2025 Apr 4;15(1):11660. doi: 10.1038/s41598-025-95315-0. Sci Rep. 2025. PMID: 40185909 Free PMC article.
-
Unravelling the Proteinopathic Engagement of α-Synuclein, Tau, and Amyloid Beta in Parkinson's Disease: Mitochondrial Collapse as a Pivotal Driver of Neurodegeneration.Neurochem Res. 2025 Apr 16;50(3):145. doi: 10.1007/s11064-025-04399-7. Neurochem Res. 2025. PMID: 40240583 Review.
-
Gut microbiota and Parkinson's Disease: a new frontier in understanding neurological health.Inflammopharmacology. 2025 May;33(5):2565-2588. doi: 10.1007/s10787-025-01726-w. Epub 2025 Apr 17. Inflammopharmacology. 2025. PMID: 40244491 Review.
-
Pivotal Role of miRNA-lncRNA Interactions in Human Diseases.Mol Biotechnol. 2024 Dec 13. doi: 10.1007/s12033-024-01343-y. Online ahead of print. Mol Biotechnol. 2024. PMID: 39673006 Review.
-
The Role and Applications of Artificial Intelligence in the Treatment of Chronic Pain.Curr Pain Headache Rep. 2024 Aug;28(8):769-784. doi: 10.1007/s11916-024-01264-0. Epub 2024 Jun 1. Curr Pain Headache Rep. 2024. PMID: 38822995 Review.
References
-
- World Health Organization . Global health estimates 2020: Disease burden by cause, age, sex by country and by region, 2000–2019. Geneva: World Health Organization; (2020).
LinkOut - more resources
Full Text Sources